4.7 Article

Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3

期刊

JOURNAL OF NUCLEAR MEDICINE
卷 57, 期 3, 页码 467-472

出版社

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.115.162628

关键词

experimental arthritis; fibroblast activation protein; macrophages; RGD peptide; therapy response

资金

  1. Roche Postdoc Fellowship (RPF) Program

向作者/读者索取更多资源

Rheumatoid arthritis is an autoimmune disease resulting in chronic synovial inflammation. Molecular imaging could be used to monitor therapy response, thus enabling tailored therapy regimens and enhancing therapeutic outcome. Here, we hypothesized that response to etanercept could be monitored by radionuclide imaging in arthritic mice. We tested 3 different targets, namely fibroblast activation protein (FAP), macrophages, and integrin alpha(v)beta(3). Methods: Male DBA/1J mice with collagen-induced arthritis were treated with etanercept. SPECT/CT scans were acquired at 1, 24, and 48 h after injection of In-111-RGD(2) (integrin alpha(v)beta(3)), In-111-anti-F4/80-A3-1 (antimurine macrophage antibody), or In-111-28H1 (anti-FAP antibody), respectively, with nonspecific controls included. Mice were dissected after the last scan, and scans were analyzed quantitatively and were correlated with macroscopic scoring. Results: Experimental arthritis was imaged with In-111-28H1 (anti-FAP), In-111-anti-F4/80-A3-1, and In-111-RGD(2). Tracer uptake in joints correlated with arthritis score. Treatment decreased joint uptake of tracers from 23 15, 8 4, and 2 1 percentage injected dose per gram (%ID/g) to 11 +/- 11 (P < 0.001), 4 +/- 4 (P < 0.001), and 1 +/- 0.2 %ID/g (P < 0.01) for In-111-28H1, In-111-anti-F4/80-A3-1, and In-111-RGD(2), respectively. Arthritis-to-blood ratios (in mice with arthritis score 2 per joint) were higher for In-111-28H1 (5.5 +/- 1; excluding values > 25), In-111-anti-F4/80-A3-1 (10.4 +/- 4), and In-111-RGD(2) (7.2 +/- 1) than for control In-111-DP47GS (0.7 +/- 0.5; P = 0.002), In-111-rat IgG(2)b (0.5 +/- 0.2; P = 0.002), or coinjection of excess RGD(2) (3.5), indicating specific uptake of all tracers in arthritic joints. Conclusion: (1111)n-28H1, In-111-anti -F4/80-A3-1, and In-111-RGD(2) can be used to specifically monitor the response to therapy in experimental arthritis at the molecular level. Further studies, however, still need to be performed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据